NIH Clinical Research Studies Listed By Protocol Number

Active Accrual, Protocols Recruiting New Patients 
* 08-NR-0132:
Evaluation and Diagnosis of Potential Research Subjects with Pain and Fatigue Syndromes

* 08-N-0161:
Noninvasive Language Mapping in Patients with Localization-Related Epilepsy

* 08-N-0153:
The Role of Autoimmunity in Neurologic Complications of Celiac Disease

* 08-N-0134:
Pilot Study of Tolerability of Lithium Therapy in Patients with Spinocerebellar Ataxia Type I (SCA1)

* 08-N-0095:
Assessment of Cerebral Circulation and Perfusion in Adults after Neonatal Carotid Occlusion

* 08-N-0045:
Investigation of the Dopamine System in Frontotemporal Dementia

* 08-N-0044:
A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)

* 08-N-0040:
The Association Between Focal Dystonia (FD) and Complex Regional Pain Syndrome (CRPS)

* 08-N-0027:
HHV6B in Epilepsy Imaging and CSF Studies

* 08-N-0023:
Motor Cortex Reward Signaling in Parkinson Disease

* 08-N-0012:
L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions with Carbidopa and Entacapone

* 08-M-0158:
PET Imaging of Peripheral Benzodiazepine Receptors Using [11C](R)-PK 11195 and [11C]PBR28

* 08-M-0154:
An Investigation of the Relationship Between Donepezil Enhanced REM Sleep, Sleep Architecture and Behavior in the Prepubertal Child with Autism

* 08-M-0150:
An Investigation to Determine Whether Levels of P11 Protein in Peripheral Blood Cells Correlate with Treatment Response to Citalopram in Patients with Major Depressive Disorder

* 08-M-0124:
Measurement of P-glycoprotein Function in Alzheimer Disease, Parkinson Disease, and Frontotemporal Dementia Using Positron Emission Tomography

* 08-M-0066:
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Dementia

* 08-M-0062:
Brain and Whole Body Imaging of P-Glycoprotein Function using [11C]dLop

* 08-M-0052:
fMRI Investigation of Cortical Reorganization and Phantom Limb Pain Following Amputation

* 08-M-0049:
Imaging of Cannabinoid CB1 Receptors Using [18F]MePPEP-d2

* 08-M-0048:
PET Test/Retest Brain Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP

* 08-M-0006:
PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Carotid Atherosclerosis

* 08-M-0002:
Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Atomoxetine on Cognitive Function in Patients with Schizophrenia and Normal Controls Based on COMT Genotype

* 08-I-0171:
VRC 015: A Phase I, Open-Label Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of a Multiclade Recombinant HIV-1 Adenoviral Vector Vaccine, VRC-HIV ADV014-00-VP, in Uninfected Adults Randomized to Needle or Biojector Methods of Int

* 08-I-0093:
A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC

* 08-I-0065:
VRC 206: A Phase I Study to Evaluate the Safety and Immunogenicity of an Ebola DNA Plasmid Vaccine, VRC-EBODNA023-00-VP, and a Marburg DNA Plasmid Vaccine, VRC-MARDNA025-00-VP, in Healthy Adults

* 08-I-0063:
A Phase III, Multicenter Placebo-Controlled, Randomized, Double-Blind Study to Evaluate Safety/Efficacy of PROCHYMALTM IV Infusion for Induction of Remission in Subjects Experiencing Tx of Refractory Moderate to Severe Crohn's Disease

* 08-I-0053:
Pilot (Phase I-II) Study of Valproic Acid (Depakote) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)

* 08-I-0034:
Validation of (1)H-Magnetic Resonance Spectroscopy for Quantification of Hepatic Triglyceride Content

* 08-HG-0122:
Patient-Provider Communication and Interaction in a Virtual Clinical Setting

* 08-HG-0059:
Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients

* 08-H-0156:
Screening of Subjects to Determine Eligibility to Safely Participate in Blood Disorders Studies

* 08-H-0108:
Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women

* 08-H-0084:
Evaluation of Systemic Toxicity Associated with Allogeneic Peripheral Blood Stem Cell Infusion

* 08-H-0081:
Identification of Biomarkers in Exhaled Breath Condensates from Asthmatic Patients

* 08-H-0067:
Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia with Heterotaxy and Complex Congenital Heart Disease

* 08-H-0047:
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Allergic Asthma

* 08-H-0046:
Co-Infusion of Umbilical Cord Blood and Haploidentical CD34+ Cells Following Nonmyeloablative Conditioning as Treatment for Severe Aplastic Anemia and MDS Associated with Severe Neutropenia Refractory to Immunosuppressive Therapy

* 08-H-0028:
Pilot Study of Monocyte Biology in Insulin Sensitive, Resistant and Diabetic Subjects

* 08-H-0016:
Effect of Fasting on the Size of Lymphangioleiomyomas in Patients with Lymphangioleiomyomatosis

* 08-EI-0169:
Evaluation and Treatment Protocol for Potential Research Participants with Ocular Diseases

* 08-EI-0147:
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia without Neovascularization (MACTEL 2)

* 08-EI-0146:
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia with Neovascularization (MACTEL 1)

* 08-EI-0135:
Pilot Validation Study of Computer Administration of Vision Targeted Quality of Life Instruments

* 08-EI-0129:
Pilot Study of Sunitinib Malate for Advanced Ocular Disease of Von Hippel-Lindau Syndrome

* 08-EI-0103:
High Speed Indocyanine Green Angiography Findings in Induction PRN Regimen of Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration

* 08-EI-0102:
Screening Study for the Evaluation and Diagnosis of Potential Research Participants

* 08-EI-0099:
Epigenetics, Molecular Genetics, and Biomarkers of Degenerative and Inflammatory Ocular Diseases

* 08-EI-0061:
Pilot Study for the Detection of Neutralizing Antibodies in Patients treated with Bevacizumab (Avastin™ (Trademark)) or Ranibizumab (Lucentis™ (Trademark))

* 08-EI-0043:
Age-Related Eye Disease Study (AREDS) Follow-Up

* 08-EI-0031:
Visual Motor Coordination

* 08-EI-0017:
Evaluation and Treatment Protocol for Potential Research Participants with Inherited Ophthalmic Diseases

* 08-DK-0165:
Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)

* 08-DK-0140:
Predicting Adaptive Thermogenesis

* 08-DK-0138:
A New Method for Determining Gastric Acid Output Using a Wireless Capsule

* 08-DK-0106:
Hepatitis C Eradication and Progression of Atherosclerosis

* 08-DK-0098:
Natural History of Familial Carcinoid Tumor

* 08-DK-0004:
High Throughput Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease

* 08-D-0018:
Clinical and Laboratory Evaluation of the Autonomic Nervous System in Primary Sjogren's Syndrome

* 08-CH-0170:
Establishment of a Fibroid Tissue Bank

* 08-CH-0139:
Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity

* 08-CH-0085:
Eating Behavior in Adolescents

* 08-CH-0022:
Treatment of Menorrhagia in Women with Aplastic Anemia: Platelet Transfusion Alone to Platelet Transfusion with Continuous Oral Contraceptive Pills

* 08-CH-0001:
Calibration of Non-Invasive Non-ionizing Imaging Techniques to Study Vasculature of Healthy Volunteers

* 08-CC-0133:
Response and Adaptation to Aerobic Exercise in Patients with Pulmonary Hypertension: Initial Studies for Establishing Guidelines

* 08-CC-0127:
Communicating a Cancer Diagnosis: Current Methods and Their Effects

* 08-CC-0032:
Parental Permission and Adolescent Assent and Decision Making in Clinical Research

* 08-CC-0024:
Immunologic and Virologic Response in HIV Infected HLA-B*57 Progressors after Infusion of Lymphocytes from HIV Infected HLA-B*57 "Elite" Long-Term-Nonprogressors

* 08-C-0168:
A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas

* 08-C-0166:
An Open Label Pilot Study to Evaluate the Effect on the Immune System of Talactoferrin in Adults with Non-Small Cell Lung Cancer (NSCLC)

* 08-C-0164:
A Phase II, Multicenter, Open-Label Trial Evaluating the Activity and Tolerability of Romidepsin (Depsipeptide, FK228) in Progressive or Relapsed Peripheral T-cell Lymphoma Following Prior Systemic Therapy

* 08-C-0162:
Transfer of Autologous T Cells Transduced with the Anti-MART-1 F5 T Cell Receptor in High Risk Melanoma

* 08-C-0155:
Phase II Study of Metastatic Cancer that Overexpresses p53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-p53 TCR-Gene Engineered Lymphocytes and Dendritic Cell Vaccination

* 08-C-0130:
A Phase II Trial of Peginterferon Alpha-2b (Pegintron) for Neurofibromatosis Type 1 Related Unresectable, Symptomatic or Life-Threatening Plexiform Neurofibromas

* 08-C-0128:
A Phase I Combination Study of AZD2281 and Cisplatin Plus Gemcitabine in Adults With Solid Tumors

* 08-C-0123:
A Phase 1, Single Center, Dose Escalation Study of CAT-8015 in Children, Adolescents, and Young Adults with Refractory CD22+ Acute Lymphoblastic Leukemia (pALL) or Non-Hodgkin's Lymphoma (NHL)

* 08-C-0121:
Phase II Study of Metastatic Cancer that Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 TCR-Gene Engineered Lymphocytes

* 08-C-0105:
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

* 08-C-0104:
Phase II Study in Patients with Metastatic Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of gp100 Reactive Peripheral Blood Lymphocytes (PBL) and High or Low Dose Aldesleukin

* 08-C-0101:
A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas

* 08-C-0097:
Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic Stem Cell Transplantation in Children and Adults

* 08-C-0096:
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

* 08-C-0092:
A Phase I Study with an Expansion Cohort of the PARP Inhibitor AZD2281 (KU-0059436) Combined with Carboplatin in Breast and Ovarian Cancer in BRCA1/2 Mutation Carriers and Familial Breast and Ovarian Cancer

* 08-C-0091:
Phase I Study of SNX-5422 Mesylate in Adults With Refractory Solid Tumor Malignancies and Lymphomas

* 08-C-0088:
Low Intensity Allogeneic Hematopietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma Using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells

* 08-C-0087:
Phase I Study of Vandetanib (ZD 6474) and Bevacizumab Combination Therapy Evaluating the VEGF and EGF Signal Transduction Pathways in Adults with Solid Tumors and Lymphomas

* 08-C-0086:
A Phase 2, Open-Label, Two Arm Trial to Evaluate the Efficacy of PF-00299804 in Patients with Advanced NSCLC After Failure of at Least One Prior Chemotherapy Regime and Failure of Prior Treatment with Erlotinib

* 08-C-0083:
Registration Ph III Study of Lucanix ™ (Trademark) in Adv NSC Lung Cancer: An Intl Mltctr RDBPC Study of Lucanix™ (Trademark) Maint Ther for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Dx Following One Reg of Front-line, P

* 08-C-0080:
SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas

* 08-C-0079:
Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults with Neurofibromatosis Type 1

* 08-C-0078:
A Phase I/II trial of Pemetrexed (Alimta [Registered Trademark]) Combined with Sirolimus (Rapamycin, Rapamune [Registered Trademark]) in Subjects with Relapsed or Refractory NSCLC Whose Tumors Bear Activation of mTOR

* 08-C-0077:
A Phase I, Multi-Institutional, Open-Label, Dose-Escalation, Multiple Dose Study of the Safety, Tolerability, and Immune Response of CRS-207 in Adult Subjects with Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates For Standard Tx

* 08-C-0075:
Phase III Evaluation of Recombinant MAGE-A3 Vaccine as Adjuvant Therapy Following Resection of MAGE-A3-Positive Non-Small Cell Lung Cancer

* 08-C-0074:
A Phase II Study of Satraplatin and Prednisone in Metastatic Androgen Independent Prostate Cancer (AIPC)

* 08-C-0071:
Phase I Study of Bortezomib and Cetuximab without or with Cisplatin in Combination with Radiation Therapy for Advanced Head and Neck Cancer

* 08-C-0051:
A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies

* 08-C-0039:
A Phase II Study of ZD6474 (Vandetanib) in Subjects with Advanced Clear Cell Renal Carcinoma

* 08-C-0035:
A Pharmacodynamic Study of the P-glycoprotein (Pgp) Antagonist, CBT-1® (Registered Trademark), Evaluating Pgp Inhibition in Tumors and Normal Tissues

* 08-C-0033:
Multicenter Phase II Study of Belinostat (PXD-101) in Previously Chemotherapy Treated Thymoma and Thymic Carcinoma

* 08-C-0030:
Phase I Trial of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb (LXS) Oral Powder (4-HPR/LXS Oral Powder) (4-HPR) in Adults With Solid Tumors and Lymphomas

* 08-C-0026:
A Phase 1, Single Center, Dose-Escalation Study of SS1(dsFv)PE38 Administered Concurrently with Pemetrexed and Cisplatin in Subjects with Unresectable Malignant Epithelial Pleural Mesothelioma

* 08-C-0020:
A Phase 2 Study of ZD6474 (Vandetanib) in Patients with Von Hippel Lindau Disease and Renal Tumors

* 08-C-0015:
A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas

* 08-C-0010:
Multiple Ascending Dose (MAD) Phase I Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Children and Adolescents with Advanced Solid Tumors

* 08-C-0007:
A Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents, and Young Adults with Treatment Refractory Cancer

* 08-AR-0029:
Phase Ib, Multicenter Randomized, Double-Blind Placebo-Controlled, Dose Escalation Study w/Open-Label Extension to Evaluate Safety and Tolerability of Multiple IV Doses of MEDI-545; A Fully Human Anti-IFN-alpha Monoclonal Antibody in Patients w/SLE

* 08-AR-0008:
Insulin Resistance and Atherosclerosis in a Sample of Women with Systemic Lupus Erythematosus

* 08-AA-0137:
A Randomized, Double-blind, Placebo Controlled Trial (RCT) of Varenicline to Reduce Alcohol Consumption in Heavy Drinkers

* 08-AA-0125:
Effect of Naltrexone on Craving and Ethanol-Induced Brain Activity

* 08-AA-0058:
Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics

* 07-N-0191:
Role of the Cortical Medial Frontal Areas in Blepharospasm

* 07-N-0190:
Neurobiological Studies of Psychogenic Movement Disorders and Non-Epileptic Seizures

* 07-N-0187:
Brain Connectivity and Sensorimotor Integration During Single/Dual Motor Tasks

* 07-N-0165:
Suppression and Facilitation of the Motor Cortex by Stimulation of the Cerebellum in Patients with Dystonia and Healthy Controls

* 07-N-0156:
Biomechanics of Human Epiglottal Movement and Inversion

* 07-N-0154:
Influence of Lesion Location on Cortical Reorganization after Chronic Stroke

* 07-N-0147:
Effect of Direct Current Brain Polarization on Verbal Memory

* 07-N-0137:
Expanding the Phenotype of the LRRK-2 Mutation in Individuals with History of Parkinson's Disease and their Relatives: a Prospective Study

* 07-N-0122:
Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System

* 07-N-0117:
BOLD-fMRI of the Perception of Volition in Functional Movement Disorders

* 07-N-0103:
Imaging Serotoninergic Neurotransmission in Epilepsy

* 07-N-0092:
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [(11)C]PBR28 in Patients with Multiple Sclerosis (MS)

* 07-N-0088:
The Characteristics of Sequence Effect in de novo and Advanced Parkinson's Disease

* 07-N-0072:
Neural Substrates of Lasting Motor Skill Learning by Spacing Effect

* 07-N-0066:
Direct Current Brain Polarization of Bilateral Prefrontal Cortex

* 07-N-0063:
Detecting a Reward Signal in the Motor Cortex

* 07-N-0050:
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems

* 07-N-0049:
Effects of tDCS Over the Cerebellum on Motor Function

* 07-N-0022:
Enhancing Interhemispheric Disinhibition Between Motor Cortices Using Bilateral Brain Stimulation

* 07-N-0020:
Evaluation of the Plasticity of the Primary Motor Cortex and Motor Learning in Parkinson's Disease

* 07-N-0014:
The Use of Magnetic Resonance Imaging to Investigate Cortical Damage in Patients with Multiple Sclerosis and Correlation with Cognitive Dysfunction

* 07-N-0010:
Enhancing Motor Memory Encoding by Action Observation

* 07-M-0209:
PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [F-18]FBR

* 07-M-0208:
PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [C-11]PBR28

* 07-M-0201:
An Investigation of the Efficacy of the Glutamate Transporter GLT 1 in the Treatment of Bipolar Depression

* 07-M-0152:
An Investigation of the Antidepressant Effects of the Selective NR2B Antagonist MK-0657 in Major Depression

* 07-M-0127:
Functional Neuroanatomy of Emotion Perception, Recognition, Learning, and Memory

* 07-M-0082:
PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

* 07-M-0036:
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY

* 07-M-0024:
Treatment of Childhood Regressive Autism with Minocycline: An Anti-Inflammatory Agent Active Within the CNS

* 07-M-0021:
Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders

* 07-I-0229:
Influenza in the Immunocompromised Host

* 07-I-0218:
A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study Assessing the Role of Pathogen-Specific IgE and Histamine Release in the Hyper-IgE Syndrome and the Effect of Ranitidine on Laboratory and Clinical Manifestations

* 07-I-0205:
An Observational Study of the Immunopathogenesis of and Response to Step-Up Inflammatory Bowel Disease Therapy for Hermansky-Pudlak Syndrome-Associated Colitis

* 07-I-0183:
The Collection of Research Samples and/or Data for Repository from Related or Unrelated Hematopoietic Stem Cell Transplantation Recipients for the National Marrow Donor Program

* 07-I-0171:
Treatment for Growth Failure in Patients with X-Linked Severe Combined Immunodeficiency (XSCID): A Phase 2 Study Assessing Safety and Clinical Response to Treatment with Insulin-like Growth Factor-1 (IGF-1)

* 07-I-0167:
VRC 012: A Phase I Clinical Trial of the Safety and Immunogenicity of an HIV-1 Adenoviral Vector Serotype 35 Vaccine: Dose Escalation as a Single Agent and Prime-Boost Schedules with an HIV-1 Adenoviral Vector Serotype 5 Vaccine in Uninfected Adults

* 07-I-0142:
Research Respiratory Tract Procedures in Healthy Adult Volunteers and Adult Patients to Obtain Specimens for In Vitro Analyses of Infection Pathogenesis and Susceptibility

* 07-I-0105:
Pioglitazone for Hepatic Steatosis in HIV

* 07-I-0094:
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV

* 07-I-0075:
Allogeneic and Matched Unrelated Donor Stem Cell Transplantation for Congenital Immunodeficiencies: Busulfan-based Conditioning with Campath- 1H or h-ATG, Radiation, and Sirolimus

* 07-I-0033:
Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility

* 07-I-0017:
Autologous Transplantation of Genetically Modified Cells for the Treatment of X-Linked Chronic Granulomatous Disease

* 07-I-0001:
An Open Label Non-Randomized Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks with Ribavirin among HIV/HCV Coinfected Individuals

* 07-HG-0132:
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome

* 07-HG-0076:
A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)

* 07-HG-0002:
ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study

* 07-H-0225:
A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients with Myelodysplastic Syndrome (MDS) and AML with Trisomy 8

* 07-H-0196:
Niacin Therapy to Improve Endothelial Function in Sickle Cell Disease

* 07-H-0177:
Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy

* 07-H-0159:
Efficacy of WT1 and PRI Peptide Vaccination for Patients with Low Risk Myeloid Malignancies

* 07-H-0136:
Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies

* 07-H-0128:
Gadofosveset Imaging of Chronic Total Peripheral Artery Occlusion (CTO)

* 07-H-0113:
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples from Normal Volunteers

* 07-H-0104:
A Phase II Study of Lenalidomide Revlimid® (Registered Trademark) in Previously Treated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

* 07-H-0091:
WTI Peptide Vaccination for Patients with High Risk Hematological Malignancies

* 07-H-0056:
Validation of Cardiac MR Perfusion with Cardiac Catheterization Physiological Assessment

* 07-H-0055:
Effects of Interleukin-1 Inhibition on C-Reactive Protein Levels, Endothelial Progenitor Cell Mobilization and Endothelial Function in Patients with Coronary Artery Disease

* 07-H-0030:
Metabolic Regulation by Tumor Suppressor p53 in Li-Fraumeni Syndrome

* 07-H-0005:
Pilot Study of Topical Dexamethasone 0.01% Solution for Prevention of Oral Chronic Graft Versus Host Disease

* 07-EI-0145:
Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome and Premature Ovarian Failure

* 07-EI-0025:
The Age-Related Eye Disease Study 2 (AREDS2): A Multi-Center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration

* 07-E-0012:
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

* 07-DK-0219:
A Nutrigenomics Intervention for the Study of the Role of Dietary Sitosterol on Lipid, Glucose and Energy Metabolism

* 07-DK-0212:
Prospective Evaluation of Albuminuria in HIV Positive Patients

* 07-DK-0207:
Tenofovir Disoproxil Fumarate Alone Versus its Combination with Emtricitabine for Treatment of Chronic Hepatitis B

* 07-DK-0202:
Thyroid Hormones Homeostasis and Energy Metabolism Changes During Exposure to Cold Temperature in Humans

* 07-DK-0163:
The Effect of Diet on Vascular Disease: A Study of Pre-Menopausal African Amercian and Caucasian Women

* 07-DK-0143:
Effects of S-Adenosyl Methionine (SAMe) on Viral and Cell Signaling Response to Combination Therapy for Chronic Hepatitis C

* 07-DK-0115:
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults with Type 2 Diabetes Mellitus

* 07-DK-0077:
Study of the Phenotype of Overweight and Obese Adults

* 07-CH-0211:
A Phase 2, Open Label, Crossover Pharmacokinetic and Pharmacodynamic Study to Compare Chronocort Versus Cortef in Patients with CAH

* 07-CH-0192:
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors

* 07-CH-0169:
Noninvasive Optical Imaging of the Effects of External Spectral Filters on Macular Autofluorescence in Pseudophakic Eyes

* 07-CH-0126:
Pilot Study of the Metabolic Effects of Betahistine Hydrochloride (Obecure) in Overweight Women

* 07-CH-0008:
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion

* 07-CC-0153:
Effects of Peripheral Blood Stem Cell Transplantation on the Microbial Flora of the Oral Cavity

* 07-CC-0125:
Pilot Study of the Incidence of HLA Class I and Class II Antibodies in Platelet Donors and their Effects on the Transfusion Recipient

* 07-CC-0090:
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders

* 07-CC-0067:
A Feasibility Study to Test an Individualized Dyadic Problem-Solving Education Intervention to Improve Problem-Solving Skills of Patients and Family Caregivers During Allogeneic HSCT

* 07-CC-0011:
Hypnosis as a Pain and Symptom Management Strategy in Patients with Sickle Cell Disease

* 07-C-0230:
A Phase II Study of Hypofractionated Highly Conformal Radiation With Helical Tomotherapy for Extra-Cranial Oligometastases

* 07-C-0228:
Phase I and Pharmacokinetic Study of Vorinostat for Solid Tumors and Lymphomas in Patients with Varying Degrees of Hepatic Dysfunction

* 07-C-0222:
Pilot Trial of the NK1 Receptor Radio-Ligand [18F]SPA-RQ: Imaging Pancreatic Ductal Adenocarcinoma

* 07-C-0220:
A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children With Refractory Solid Tumors

* 07-C-0210:
Phase I/II Study Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of Allogeneic Tumor-Reactive Lymphocyte Cell Line DMF5 in Metastatic Melanoma

* 07-C-0206:
A Pilot Study of Tumor Vaccination in Patients with Neuroblastoma and Pediatric Sarcomas and Altered T-Cell Homeostasis

* 07-C-0203:
A Phase I Study of ABT-888 in Combination With Topotecan Hydrochloride in Adults With Refractory Solid Tumors and Lymphomas

* 07-C-0200:
A Phase 1, Multicenter, Dose-Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

* 07-C-0195:
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Unrelated Donors and Utilizing Two Graft-Versus-Host Disease Prophylaxis Regimens

* 07-C-0189:
Phase I/II Trial of Vandetanib (ZD6474, ZACTIMA) in Children and Adolescents with Hereditary Medullary Thyroid Carcinoma

* 07-C-0188:
A Double-Blind Randomized Phase 2.5 Trial of ONY-P1 Vaccine Versus Placebo in Men with D0 Prostate Cancer Following Limited Androgen Ablation

* 07-C-0176:
A Phase II Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen in Metastatic Melanoma

* 07-C-0175:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes

* 07-C-0174:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-gp100:154-162 TCR-Gene Engineered Lymphocytes

* 07-C-0166:
A Phase I Study of BMS-354825 (DASATINIB) in Children with Recurrent/Refractory Solid Tumors or Imatinib Resistent PH Plus Leukemia

* 07-C-0138:
A Phase II Trial of GW786034 (Pazopanib) in Subjects with Recurrent Glioblastoma

* 07-C-0134:
A Phase II Study of Combination Oral CC-5013 Lenalidomide (Revlimid ® (Registered Trademark)), Oral Sunitinib (Sutent) and Low Dose Oral Metronomic Cyclophosphamide for the Treatment of Stage IV Ocular Melanoma

* 07-C-0133:
Phase I Study of Topical Romidepsin (Depsipeptide) in Early Stage Cutaneous T-Cell Lymphoma

* 07-C-0130:
A Phase 1, Multicenter, Dose-Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Hairy Cell Leukemia (HCL)

* 07-C-0123:
Pilot Trial to Identify and Characterize Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer

* 07-C-0121:
A Phase 2 Study of the c-Met RTK Inhibitor GSK1363089 (Formerly XL880) in Subjects with Papillary Renal-Cell Carcinoma (PRC)

* 07-C-0114:
A Phase I Study of Subcutaneous CYT 107 (Interleukin-7) in Refractory Metastatic Melanoma or Renal Cell Carcinoma

* 07-C-0111:
A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies

* 07-C-0110:
Analysis of Stored Data Collected from Individuals Administered Neurobehavioral Assessments on IRB-Approved Protocols

* 07-C-0108:
A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL), Prolymphocytic Leukemia (PLL), or Small Lymphocytic Lymphoma (SLL)

* 07-C-0107:
A Randomized Phase II Trial Combining Vaccine Therapy with PROSTVAC/TRICOM and Flutamide vs. Flutamide Alone in Men with Androgen Insensitive, Non Metastatic (D0.5) Prostate Cancer

* 07-C-0106:
A Randomized Phase 2.5 Study of (153)Sm-EDTMP (Quadramet) With or Without a PSA/TRICOM Vaccine in Men With Androgen-Insensitive Metastatic Prostate Cancer

* 07-C-0101:
A Phase 0 Trial of (111)Indium CHX-A" DTPA trastuzumab Imaging in Cancer

* 07-C-0100:
Collection of Blood from Patients with Prostate Cancer

* 07-C-0097:
A Phase I Study of Batracylin (NSC320846) in Subjects with Solid Tumors and Lymphomas

* 07-C-0087:
A Natural History Study of HIV Acquired in Infancy or Childhood

* 07-C-0086:
Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures

* 07-C-0085:
An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults with Metastatic, Recurrent, or Progressive Cancer or HIV Disease

* 07-C-0081:
A Phase I/II Study of Flavopiridol in Relapsed or Refractory Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma (DLBCL)

* 07-C-0074:
A Phase II Study of ABT-751, an Orally Bioavailable Tubulin Binding Agent, in Children with Relapsed or Refractory Neuroblastoma

* 07-C-0064:
Adoptive Cell Therapy for B-Cell Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation with Costimulated, Tumor-Derived Lymphocytes

* 07-C-0061:
Phase II Study of Clinical Activity and Proteomic Pathway Profiling of the VEGFR2 Inhibitor, Vandetanib in Women With Relapsed or Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

* 07-C-0060:
Prospective Evaluation of Tumor Angiogenesis in Endocrine Neoplasms

* 07-C-0059:
A Phase II Study of AZD2171 in Metastatic Androgen Independent Prostate Cancer

* 07-C-0058:
A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer

* 07-C-0053:
A Phase I Trial of Enzastaurin (LY317615) in Combination with Carboplatin in Adults with Recurrent Gliomas

* 07-C-0052:
A Phase 2 Study of O6-Benzylguanine (O(6)-BG) and Temozolomide in Patients with Glioblastoma Progressing at Least 3 Months After Completion of Primary Treatment with Radiation Therapy and Temozolomide

* 07-C-0047:
A Phase I Trial of Nelfinavir (Viracept) in Adults with Solid Tumors

* 07-C-0043:
An Evaluation of the Tissue Distribution and the Selective Tumor Trafficking of TNF-Bound Colloidal Gold (CYT-6091) Following Intravenous Administration in Subjects with Primary and Metastatic Cancer Undergoing Surgical Resection

* 07-C-0040:
A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) in Patients with Refractory Pediatric Solid Tumors

* 07-C-0027:
A Multi-Center Study of the Safety, Tolerability, Pharmacokinetics, and Dose Escalation of Intravenous Recombinant Human Mannose-Binding-Lectin (rhMBL) in MBL Deficient Pediatric Hematology/Oncology Patients with Fever and Neutropenia

* 07-C-0006:
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects with Relapsed or Refractory Lymphoid Malignancies

* 07-C-0003:
Phase II Study of Metastatic Cancer that Overexpresses p53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-p53 TCR-Gene Engineered Lymphocytes

* 07-AT-0089:
An Exploratory Study to Evaluate the Ability of Epigallocatechin Gallate to Simultaneously Improve Metabolic and Cardiovascular Actions of Insulin in Healthy, Obese, Hypertensive, or Diabetic Subjects

* 07-AA-0026:
OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine

* 06-NR-0229:
Neurotropin Treatment of Fibromyalgia

* 06-N-0243:
Brain Connectivity Between Visual Input and Motor Output

* 06-N-0242:
The Effect of Surround Inhibition During Phasic Compared to Tonic Voluntary Finger Movement in Focal Hand Dystonia

* 06-N-0232:
Hypersensitivity in Tourette Syndrome: An Evaluation of Perceived Intensity Versus Threshold

* 06-N-0225:
Influencing Motor Performance in Patients with Stroke by Combined Theta Burst Stimulation and Carbidopa-Levodopa

* 06-N-0224:
Collection of Blood Samples for DNA Analysis in Motor Neuron Diseases

* 06-N-0212:
A Comparison of an Implanted Neuroprosthesis with Sensory Training for Improving Airway Protection in Chronic Dysphagia

* 06-N-0209:
Plasma Exchange for Autoimmune Autonomic Failure

* 06-N-0192:
Blepharospasm and the Experimental Modulation of Cortical Excitability in Primary and Secondary Motor Areas. A Pilot Study.

* 06-N-0187:
Anticonvulsive Effects of Transcranial DC Stimulation in Pharmacoresistant Focal Epilepsy

* 06-N-0174:
Cortical Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis

* 06-N-0161:
Long-Term Motor Learning in Focal Hand Dystonia

* 06-N-0154:
An Exploratory Study on Detection of Cortical and White Matter Damage in Patients with Multiple Sclerosis Using Magnetic Resonance Imaging at 7 Tesla

* 06-N-0138:
Long-Term Improvement in Training Effects by Transcranial DC Stimulation

* 06-N-0128:
fMRI Studies of Task Specificity in Focal Hand Dystonia

* 06-N-0126:
Neurophysiology of Task-Specificity of Focal Hand Dystonia

* 06-N-0125:
Physiology of Weakness with Movement Disorders

* 06-N-0120:
Induction of Volitional Swallowing in Chronic Dysphagia Post Stroke: A Novel Mechanism-Based Intervention

* 06-N-0095:
Contribution of Interhemispheric Inhibition to Motor Learning

* 06-N-0085:
Two-Compartment Model of Diffusion Tensor Magnetic Resonance Imaging (DT-MRI) for the Diagnosis of Glioma Tumor Recurrence versus Radiation Necrosis

* 06-N-0084:
Brain Networks Responsible for Sense of Agency: An EEG Study

* 06-N-0080:
Implicit Tactile Learning in Chronic Stroke Enhanced by Non-Invasive Brain Stimulation of the Somatosensory Cortex

* 06-N-0048:
Changes in Activation Patterns in the Ventro-Medial Prefrontal Cortex of Healthy Adolescents During the Imagination and Observation of Aggressive Behavior

* 06-N-0047:
Reference Values for Plasma Catechols

* 06-N-0031:
Evaluation of Density and Pattern of Distribution of GABA A Receptors in the Brain of Patients with Focal Hand Dystonia Studied with PET using [11C] Flumazenil

* 06-N-0027:
Neuropsychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure

* 06-N-0023:
Brain Networks Responsible for Self-Agency: An fMRI study

* 06-N-0022:
PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency

* 06-N-0012:
Moving a Paralyzed Hand Through a Brain-Computer Interface Controlled by the Affected Hemisphere After Stroke

* 06-M-0253:
Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder

* 06-M-0246:
PET Scanning of Brain Dopaminergic Signal Transduction Involving Arachidonic Acid in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

* 06-M-0234:
The Antidepressant Efficacy of the Anticholinergic Scopolamine

* 06-M-0215:
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE 4) in Depressed Patients

* 06-M-0214:
PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome

* 06-M-0162:
An Investigation Examining the Evidence for Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder

* 06-M-0155:
Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders

* 06-M-0102:
Clinical and Immunological Investigations of Subtypes of Autism

* 06-M-0065:
The Evaluation of Patients with Autism Spectrum Disorders and Healthy Volunteers

* 06-M-0002:
PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]rolipram

* 06-I-0237:
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Ebola Adenoviral Vector Vaccine, VRC-EBOADV018-00-VP, in Healthy Adults

* 06-I-0235:
A Phase II Vaccine Dose Finding Pilot Study for Development of an Anti-Influenza A (H5N1) Intravenous Hyper-Immune Globulin

* 06-I-0217:
Genetic Disorders of Mucociliary Clearance

* 06-I-0207:
Investigation of Southern Tick-Associated Rash Illness (STARI)

* 06-I-0197:
A Randomized Placebo Controlled Trial of Atorvastatin in HIV Positive Patients Not on Antiretroviral Medications with the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers

* 06-I-0160:
Infliximab Treatment for Crohn's-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences

* 06-I-0106:
High Dose Versus Standard-Dose Oseltamivir for the Treatment of Severe Influenza and Avian Influenza: A Phase II Double-Blind, Randomized Clinical Trial

* 06-I-0086:
A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients with CD4 Count Less Than or Equal to 100 Cells/micro L Who Are Initiating Antiretroviral Therapy

* 06-I-0077:
Voriconazole Plasma Concentration and Toxicity

* 06-I-0074:
Collection of Blood from Persons with Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research

* 06-I-0049:
Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

* 06-I-0032:
Pilot Study of Omalizumab (Xolair) in Hyper IgE (Job's) Syndrome

* 06-I-0030:
Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells with Induration Measured in the Tuberculin Skin Test (TST)

* 06-I-0015:
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

* 06-I-0005:
Evaluation of Risk Factors for Development of Epstein-Barr Virus Lymphoproliferative Disease

* 06-HG-0134:
Natural History and Biology of Dermal Neurofibromas in Neurofibromatosis Type 1

* 06-HG-0055:
Functional Imaging using Positron Emission Tomography (PET) in Subjects with Glucocerebrosidase Mutations

* 06-H-0249:
Magnetic Resonance Angiography (MRA) in the Diagnosis of Atherosclerotic Disease Using High Field (3T) MRI Scanners: A Pilot Technical Development Study

* 06-H-0248:
Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back

* 06-H-0228:
A Pilot Study of Fractionated Dose Subcutaneous Rituximab (RTX, Rituxan® (Registered Trademark)) in Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia

* 06-H-0222:
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease

* 06-H-0203:
Catheter-Based Treatment of Cardiovascular Disease in Patients

* 06-H-0202:
Cardiopulmonary Function Assessment and NO Based Therapies for Patients with Hemolysis-Associated Pulmonary Hypertension

* 06-H-0190:
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Alemtuzumab (Campath)

* 06-H-0165:
Evaluation of Endothelial and Hemodynamic Function in HIV Associated Pulmonary Hypertension and a Phase I/II Safety and Efficacy Trial of Sildenafil in HIV Associated Pulmonary Hypertension

* 06-H-0156:
A Pilot Study of the Safety and Activity of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers

* 06-H-0072:
Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial

* 06-H-0054:
Evaluation of Synergy of Combining Hydroxyurea with Recombinant Human Erythropoietin Glycoform Alpha (rhu Erythropoietin-alpha) on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

* 06-H-0034:
A Randomized Study of Three Immunosuppressive Regimens in Treatment Naive Patients with Severe Aplastic Anemia: Horse-ATG/CsA Taper vs Rabbit-ATG/CsA vs Alemtuzumab

* 06-EI-0252:
A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism

* 06-EI-0236:
National Ophthalmic Genotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases

* 06-EI-0230:
Family Studies of Uveal Coloboma

* 06-EI-0111:
Treatment of Choroidal Subretinal Neovascularization with Agents Directed Against the Immune Response

* 06-EI-0068:
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease

* 06-EI-0059:
Clinical and Molecular Studies in Families with Glaucoma and Related Diseases

* 06-EI-0058:
Clinical and Molecular Studies in Families with Myopia and Related Diseases

* 06-EI-0050:
Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol

* 06-EI-0046:
Treatment of Non-Infectious Intermediate and Posterior Uveitis Associated Macular Edema with Humanized Anti-CD11a Antibody Therapy

* 06-EI-0044:
Phenotype-Genotype Correlation in Aniridia

* 06-DK-0183:
Gene Expression and Release of Inflammatory Mediators in Overweight Subjects Before and After Weight Loss

* 06-DK-0142:
Peripheral Blood Collection of Adult Stem Cells

* 06-DK-0133:
Thyroid Hormone-Induced Lipolysis: An In Vivo Microdialysis Study

* 06-DK-0079:
The Role of the Orexin System in Body Weight Regulation: Patients with Narcolepsy

* 06-DK-0036:
Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity

* 06-DK-0025:
The Effects of Lithium Carbonate on Low Dose Radioiodine Ablation in Early Thyroid Cancer Treatment

* 06-DK-0020:
Kidney Disease Biomarkers

* 06-DC-0218:
Neural Modeling and Brain Imaging of Tinnitus

* 06-D-0206:
Open-Label, Dose-Escalation Study Evaluating the Safety of a Single Administration of AdhAQP1, an Adenoviral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals with Irradiation-Induced Parotid Salivary Hypofunction

* 06-D-0188:
Physiologic Regulation of FGF-23

* 06-D-0181:
A Randomized, Placebo Controlled, Proof of Concept, Study of Raptiva, a Humanized Anti-CD-11a Monoclonal Antibody, in Patients with Sjogren's Syndrome

* 06-D-0144:
Diagnosis, Evaluation and Treatment of Patients in Need of Third Molar Removal

* 06-CH-0223:
Biobehavioral Study of Recently Adopted Children in the Baltimore-Washington Metropolitan Area

* 06-CH-0186:
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C

* 06-CH-0141:
Non-Exercise Activity Thermogenesis (NEAT) in Children

* 06-CH-0119:
Insulin Resistance and Breast Cancer: Implications for Preventive Counseling in Familial and Sporadic Cases

* 06-CH-0090:
Evaluation of Whether the Selective Progesterone Receptor Modulator CDB-2914 Can Shrink Leiomyomata

* 06-CH-0038:
Body Heat Content and Dissipation in Obese and Normal Weight Adults

* 06-CH-0011:
Natural History Study of Patients with Excess Androgen

* 06-CH-0010:
Remodeling of Chromatin-Based Epigenetic Structures in Development and Aging

* 06-CC-0193:
Transplant-Related Accelerated Progression of Hepatitis C (TRAP-C)

* 06-CC-0166:
Iron Replacement in Blood Donors

* 06-CC-0153:
A Pilot Study of Hepatic Fibrosis in HIV/AIDS Patients with Chronically Elevated Transaminases on Antiretroviral Therapy

* 06-C-0250:
A Phase II Trial of Bevacizumab and Irinotecan for Patients with Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment w/Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)

* 06-C-0233:
A Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias

* 06-C-0227:
Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies

* 06-C-0221:
A Phase I Trial of 5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Advanced Malignancies

* 06-C-0219:
An Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy in Pediatric Patients with Central Nervous System Tumors

* 06-C-0211:
A Pilot Study to Investigate the Safety and Immunogenicity of a Peptide Vaccine for HIV Infected HLA-A2 Individuals Designed to Impede the Development of Antiretroviral Resistance

* 06-C-0204:
A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Women Who Elect to Undergo Surgery that Results in the Removal of Both Ovaries

* 06-C-0198:
A Pilot Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

* 06-C-0177:
Microarray Analysis of the Effect of Cyclosporine Therapy on Gene Expression Patterns in Large Granular Lymphocytic Leukemia

* 06-C-0169:
Phase II Study in Metastatic Melanoma or Kidney Cancer using Autologous Natural Killer Cells Plus Aldesleukin (IL-2) Following a Lymphodepleting Chemotherapy

* 06-C-0167:
A Phase I Trial of TNF-Bound Colloidal Gold (CYT-6091) by Intravenous Administration in Subjects with Advance Solid Organ Malignancies

* 06-C-0164:
A Phase II Study of BAY 43-9006 (Sorafenib) in Combination with Cetuximab (Erbitux) in EGFR Expressing Metastatic Colorectal Cancer (CRC)

* 06-C-0152:
Phase I Trial of CEDIRANIB (AZD2171), an Orally Bioavailable Antiangiogenic Agent, in Children and Adolescents with Refractory or Recurrent Solid Tumors or Acute Myelogenous Leukemia

* 06-C-0150:
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for CD25 Positive Hairy Cell Leukemia

* 06-C-0146:
Phase II Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Children and Young Adults with Refractory Solid Tumors

* 06-C-0118:
A Study Evaluating the Agreement of Devices for Measuring Temperature in Children

* 06-C-0115:
Studies on the Mechanism of Action of High-dose IL-2 in Metastatic Melanoma and Renal Cell Cancer

* 06-C-0112:
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with High Grade Gliomas

* 06-C-0088:
A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver

* 06-C-0083:
Phase I and Pharmacokinetic Study of BAY 43-9006 (Sorafenib) in Patients with Kaposi's Sarcoma

* 06-C-0069:
Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High Risk Melanoma

* 06-C-0064:
A Phase II Trial of Bevacizumab for Patients with Recurrent High-Grade Gliomas

* 06-C-0063:
A Phase I/II Trial of ZD6474 for Patients with Recurrent High-Grade and Progressive Low-Grade Gliomas

* 06-C-0060:
Dermoscopic Diagnosis, Histopathological Correlation, and Cellular Immortalization of Melanocytic Nevi and Primary Cutaneous Melanoma

* 06-C-0052:
A Phase I Study of CC-5013 (Lenalidomide, NSC 703813, IND 70116) in Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome

* 06-C-0051:
AIDS-related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate with Rituximab Leucovorin Rescue and Highly Active Antiretroviral Therapy

* 06-C-0043:
Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Unresectable Malignant Peripheral Nerve Sheath Tumors

* 06-C-0014:
Prospective Evaluation of Epigenetic Alterations in Patients with Thoracic Malignancies

* 06-AT-0016:
A Randomized Study of the Effect of Tai Chi Chuan Compared to a Structured Exercise Program on Parameters of Physical Fitness and Stress in Adult Cancer Survivors

* 05-N-0228:
The Role of Cortical Coherence in Focal Hand Dystonia

* 05-N-0224:
Cortical Excitability in Succinic Semialdehyde Dehydrogenase Deficiency

* 05-N-0223:
Clinical Neurophysiology: Training and Normative Values

* 05-N-0189:
Neuropathological Basis of Spasmodic Dysphonia and Related Voice Disorders

* 05-N-0179:
MRI Measurement of Brain Metabolism Across the Sleep-Wake Cycle

* 05-N-0142:
Effects of Unilateral and Bilateral Training on Motor Function in Chronic Stroke

* 05-N-0122:
Placebo Controlled Study of the Therapeutic Effect of the Transcranial Electrical Polarization in Patients with Focal Hand Dystonia

* 05-N-0094:
Impaired Motor Learning and LTP/LTD-like Plasticity in Dystonia, are Associated with Abnormal Modulation of Cortical Excitability by Somatosensory Volleys

* 05-N-0075:
Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Long-Term Intravenous Nitrite Infusion in Healthy Volunteers

* 05-N-0063:
NINDS Biomarkers in Multiple Sclerosis Study (BioMS)

* 05-N-0039:
An Exploratory Study on Detection of Cortical Damage in Patients with Multiple Sclerosis Using Magnetic Resonance Imaging

* 05-M-0225:
An Investigation of the Efficacy in Childhood Obsessive-Compulsive Disorder of Riluzole: An Antiglutamatergic Agent

* 05-M-0198:
Effect of D-cycloserine on Treatment of Social Phobia

* 05-M-0169:
Dopamine Receptor Imaging in Mood Disorders

* 05-M-0157:
Top-Down Attentional Control of Visual Processing

* 05-M-0147:
Investigating the Role of Norepinephrine in Emotional Processing through Alpha-2 Adrenergic Receptor Modulation

* 05-M-0144:
MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain

* 05-M-0110:
Intermediate Phenotype and Genetic Mechanisms for Psychosis and Cognitive Disturbance in 22q11.2-Hemideletion Syndrome

* 05-M-0105:
Investigating the Neuro-Cognitive Underpinnings of the Emotional Dysfunction Linked to Childhood Behavioral Disturbance

* 05-M-0102:
Neurobiological Mechanisms in Panic Disorder: Behavioral, Genetic, & Neural Correlates of Noradrenergic Function

*